Showing 1731-1740 of 3038 results for "".
- Aviceda Announces Dosing of First Patient With AVD-104, a Novel Glyco-Mimetic Nanoparticle for the Treatment of GAhttps://modernod.com/news/aviceda-announces-dosing-of-first-patient-with-avd-104-a-novel-glyco-mimetic-nanoparticle-for-the-treatment-of-ga/2481647/Aviceda Therapeutics announced the dosing of its first patient with AVD-104 in its phase 2 SIGLEC trial by Ashkan Abbey, MD, of Texas Retina Associates in Dallas. This lead intravitreal asset is a novel glycan-coated nanoparticle, supported by a uniquely strong preclinical in
- TearRestore Announces First of Its Kind Dry Eye Solutions; Now Available at Walmarthttps://modernod.com/news/tearrestore-announces-first-of-its-kind-dry-eye-solutions-now-available-at-walmart/2481643/TearRestore announced that its Thermal Mask and Eyelid Wipes will now be available at participating Walmart stores nationwide and at Walmart.com. Both products will be available for recommendation for dry eye by Walmart’s in-store optometrists. &ldqu
- Norlase Secures $11M in New Funding Following Regulatory Clearance of ECHO Pattern Laserhttps://modernod.com/news/norlase-secures-11m-in-new-funding-following-regulatory-clearance-of-echo-pattern-laser/2481634/Norlase announced it has secured $11 million in funding, its largest investment round thus far. Norlase said the funding will enable it to accelerate the production ramp-up of the ECHO pattern laser, which just received FDA clearance and CE Mark earlier this month, as well as
- FDA Approves Bausch + Lomb and Novaliq's Miebo for the Treatment of the Signs and Symptoms of Dry Eye Diseasehttps://modernod.com/news/bausch-lomb-and-novaliq-announce-fda-approval-of-miebotm-perfluorohexyloctane-ophthalmic-solution-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/2481625/Bausch + Lomb announced on Thursday that the FDA has approved Miebo (perfluorohexyloctane ophthalmic solution; formerly known as NOV03) for the treatment of the signs and symptoms of dry eye disease (DED). The comapnies say Miebo is the first and only FDA-approved treatment fo
- Novel Imaging Technology Reveals Role of Immune Cells in Early Diabetic Cataract Developmenthttps://modernod.com/news/novel-imaging-technology-reveals-role-of-immune-cells-in-early-diabetic-cataract-development-1/2481623/Novel findings from researchers at the Brigham and Women's Hospital and Harvard Medical School, in collaboration with the Health Campus Göttingen in Germany, contradict previous notions about sugar's role in the onset of diabetic cataracts, according to a University Medical Center G&
- Lenstar Myopia Now Includes New AMMC Framework by Prof. Dr. Hakan Kaymakhttps://modernod.com/news/lenstar-myopia-now-includes-new-ammc-framework-by-prof-dr-hakan-kaymak/2481558/Haag-Streit has announced that the Lenstar Myopia now includes the new AMMC framework by Prof. Dr. Hakan Kaymak. The new Age-Matched Myopia Control (AMMC) framework is designed to provide diagnostic support based on the eye’s axial growth for myopia m
- Nidek Launches the NT-1/1e Non Contact Tonometerhttps://modernod.com/news/nidek-launches-the-nt-11e-non-contact-tonometer/2481535/Nidek has announced the launch of the NT-1/1e non contact tonometer models. As an addition to same series that includes the NT-1p, the NT-1/1e non-contact tonometers were developed without the pachymetry function to address market demand. The NT-1p/1 perform fully automated measur
- Nova Eye Medical Announces US Market Clearance of the iTrack Advance Canaloplasty Devicehttps://modernod.com/news/nova-eye-medical-announces-us-market-clearance-of-the-itrack-advance-canaloplasty-device/2481530/Nova Eye Medical announced that it has been granted FDA 510(k) clearance for its new canaloplasty device, iTrack Advance. The iTrack Advance has been cleared for microcatheterization and viscodilation to reduce IOP in adult patients with prim
- Horus Pharma Group Launches Nordic Subsidiaryhttps://modernod.com/news/horus-pharma-group-launches-nordic-subsidiary/2481515/Horus Pharma, an independent French laboratory specializing in ophthalmology, has opened of a new subsidiary. From its base in Stockholm, Sweden, Horus Pharma Nordic will cover Sweden, Norway, Finland and Denmark. Horus Pharma develops, patents and markets preservative-free ey
- TearRestore’s Thermal Mask & HylaWipe Tea Tree Eyelid Wipes Now Available at Targethttps://modernod.com/news/tearrestores-thermal-mask-hylawipe-tea-tree-eyelid-wipes-now-available-at-target/2481508/TearRestore announced that its Thermal Mask and Eyelid Wipes will now be available at Target stores nationwide and at Target.com. The Thermal Mask and Eye Wipe offer alternative options to artificial tears and are designed to directly address the